The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Creatinine clearance and serum albumin as factors for encephalopathy with ambulatory 14-day infusional ifosfamide for advanced liposarcomas.
S. M. Alam
No relevant relationships to disclose
C. Benson
No relevant relationships to disclose
R. L. Jones
No relevant relationships to disclose
E. Thanopoulou
No relevant relationships to disclose
S. Mitchell
No relevant relationships to disclose
O. Al-Muderis
No relevant relationships to disclose
A. Dunlop
No relevant relationships to disclose
C. Propert-Lewis
No relevant relationships to disclose
I. R. Judson
No relevant relationships to disclose
M. R. Scurr
No relevant relationships to disclose